losartan has been researched along with Cardiovascular Pregnancy Complications in 9 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Excerpt | Relevance | Reference |
---|---|---|
" We report a chronic hypertensive pregnant woman treated with losartan before and throughout pregnancy." | 3.74 | [Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case]. ( Catalán M, J; Hasbún H, J; Parra C, M; Salinas Q, S; San Martín O, A; Valdés R, E, 2008) |
" The mother suffered from essential hypertension and was treated with Cozaar (losartan 50 mg)." | 3.73 | Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists. ( Daïkha-Dahmane, F; Jugie, M; Lenclen, R; Levy-Beff, E, 2006) |
" We report a premature infant born to a 41-year-old mother with a long history of infertility who had received losartan therapy for hypertension throughout an undetected pregnancy." | 3.73 | Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant. ( Bass, JK; Faix, RG, 2006) |
"We report a case of maternal exposure to the antihypertensive drug losartan during weeks 20-31 of pregnancy." | 3.71 | Losartan and fetal toxic effects. ( Hagiwara, A; Ijiri, R; Saji, H; Yamanaka, M, 2001) |
"Losartan is a specific angiotensin II receptor antagonist." | 1.32 | Losartan induced fetal toxicity. ( Aggarwal, R; Malhotra, N; Nayar, B; Singhal, A, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (88.89) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasbún H, J | 1 |
Valdés R, E | 1 |
San Martín O, A | 1 |
Catalán M, J | 1 |
Salinas Q, S | 1 |
Parra C, M | 1 |
Gersak, K | 1 |
Cvijic, M | 1 |
Cerar, LK | 1 |
Saito, T | 1 |
Musha, Y | 1 |
Miyakawa, M | 1 |
Itoh, S | 1 |
Ohtsuji, M | 1 |
Hanson, MA | 1 |
Takeda, S | 1 |
Nayar, B | 1 |
Singhal, A | 1 |
Aggarwal, R | 1 |
Malhotra, N | 1 |
Daïkha-Dahmane, F | 2 |
Levy-Beff, E | 1 |
Jugie, M | 1 |
Lenclen, R | 1 |
Bass, JK | 1 |
Faix, RG | 1 |
Saji, H | 1 |
Yamanaka, M | 1 |
Hagiwara, A | 1 |
Ijiri, R | 1 |
Lambot, MA | 1 |
Vermeylen, D | 1 |
Noël, JC | 1 |
Martinovic, J | 1 |
Benachi, A | 1 |
Laurent, N | 1 |
Gubler, MC | 1 |
9 other studies available for losartan and Cardiovascular Pregnancy Complications
Article | Year |
---|---|
[Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case].
Topics: Acute Kidney Injury; Adult; Angiotensin II Type 1 Receptor Blockers; Creatinine; Female; Gestational | 2008 |
Angiotensin II receptor blockers in pregnancy: a report of five cases.
Topics: Abnormalities, Drug-Induced; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphe | 2009 |
Angiotensin II receptor antagonist reduces subsequent uterine arterial dysfunction in pregnant offspring of protein-restricted rat dams.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II Type 1 Receptor B | 2012 |
Losartan induced fetal toxicity.
Topics: Abnormalities, Drug-Induced; Antihypertensive Agents; Female; Fetal Death; Heart Defects, Congenital | 2003 |
Foetal kidney maldevelopment in maternal use of angiotensin II type I receptor antagonists.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Diseases in Twins; Fema | 2006 |
Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Humans; Hypertension; Inf | 2006 |
Losartan and fetal toxic effects.
Topics: Adult; Antihypertensive Agents; Contraindications; Female; Fetal Death; Humans; Losartan; Oligohydra | 2001 |
Angiotensin-II-receptor inhibitors in pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Antihypertensive Agents; Cesarean Secti | 2001 |
Fetal toxic effects and angiotensin-II-receptor antagonists.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensi | 2001 |